NOVELMED

We are a privately-held biotechnology company developing novel therapies for orphan and non-orphan diseases with a specific focus on blocking certain parts of the immune system involved in the disease process. With our unique portfolio of neutralizing monoclonal antibodies, NovelMed is targeting chronic diseases with large market potential and unmet medical need... NovelMed Therapeutics is a privately held biotechnology company that has developed cutting-edge highly selective therapeutics for complement-mediated diseases.

Also known as: NovelMed Inc., NovelMed Therapeutics, NovelMed Therapeutics, Inc.

Primary location: Cleveland United States